ASRS 2024: Diabetic Retinopathy Symposium II
Vishal Swaminathan, MD Mayo Clinic, Rochester, MN The Diabetic Retinopathy Symposium II at the 2024 ASRS meeting featured a great discussion on the use of various agents for the treatment…
Vishal Swaminathan, MD Mayo Clinic, Rochester, MN The Diabetic Retinopathy Symposium II at the 2024 ASRS meeting featured a great discussion on the use of various agents for the treatment…
Jovi CY Wong, MD, MSc, DPhil University of Toronto The American Society for Retina Specialists annual meeting in Stockholm, Sweden, kicked off with the Wet AMD Symposium I focusing mainly…
Michael Yu, MD Wills Eye Hospital, Philadelphia, PA Every year, the Champalimaud Foundation, in conjunction with the Association for Research in Vision and Ophthalmology (ARVO), recognizes an organization which overcomes…
Seyedeh Maryam Zekavat, MD, PhD Mass Eye and Ear, Broad Institute of MIT & Harvard, Boston, MA The Proctor award honors outstanding research in the basic or clinical sciences. This…
David Fell, MD Vitreoretinal fellow Tufts/OCB Dave Brown Interviews Food and Drug Administration Director of the Division of Ophthalmology, Wiley Chambers, MD. With the audience eagerly awaiting insider discussions on…
Luke Oh, MD Columbia University, New York, NY The “Non-neovascular AMD” section of ACRC 2024 started with three excellent talks moderated by Drs. Alexander Brucker and Srinivas Sadda. These presentations…
Prashant Tailor, MD Mayo Clinic, Rochester, MN For the debate on Current Complement Inhibition Therapy for Geographic Atrophy is Acceptable, we had Dr. Chakravarthy (Pro) and Dr. Spaide (Con). Dr.…
Prashant Tailor, MD Mayo Clinic, Rochester, MN In his talk titled “What’s Next in Wet AMD,” Dr. Peter Kaiser delved into the latest advancements and future directions in the treatment…